Boehringer Ingelheim sued the federal government to block Medicare price negotiations shortly before its diabetes drug was picked for negotiations.

Boehringer Ingelheim Sues to Block Medicare Price Negotiations

August 31, 2023 William Newton, Associate Editor/Senior Writer Views

Drug maker Boehringer Ingelheim (BI) sued the federal government to block Medicare price negotiations shortly before the Department of Health [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!